US Edition
New Real-world Study Reveals Oral Corticosteroid Overuse in Patients with Chronic Rhinosinusitis with Nasal Polyps - Life Sciences British Columbia
Summary by lifesciencesbc.ca
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
New Real-world Study Reveals Oral Corticosteroid Overuse in Patients with Chronic Rhinosinusitis with Nasal Polyps - Life Sciences British Columbia
According to the ACTIONS study, 39% of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) faced overexposure to oral corticosteroids (OCS) before beginning biologic therapy. ACTIONS was carried out by GSK in collaboration with Asthma Canada and leading Canadian Rhinologists. MISSISSAUGA, ON – A new Canadian real-world study, ACTIONS (chAracterizing oral Corticosteroid use in patients with chronic rhInOsinusitis with Nasal polypS in …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
